ID: ALA3343587

Max Phase: Preclinical

Molecular Formula: C38H38N5O11PS2

Molecular Weight: 835.85

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](COP(=O)(OCC(c3ccccc3)S(=O)(=O)c3ccccc3)OCC(c3ccccc3)S(=O)(=O)c3ccccc3)O2)c(=O)[nH]c1=O

Standard InChI:  InChI=1S/C38H38N5O11PS2/c1-27-23-43(38(45)40-37(27)44)36-22-32(41-42-39)33(54-36)24-51-55(46,52-25-34(28-14-6-2-7-15-28)56(47,48)30-18-10-4-11-19-30)53-26-35(29-16-8-3-9-17-29)57(49,50)31-20-12-5-13-21-31/h2-21,23,32-36H,22,24-26H2,1H3,(H,40,44,45)/t32-,33+,34?,35?,36+,55?/m0/s1

Standard InChI Key:  JIFZVHJFXHETEF-IPEWHYDHSA-N

Associated Targets(Human)

Plasma 7708 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MCF7 126967 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SW-620 52400 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

143B 353 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 835.85Molecular Weight (Monoisotopic): 835.1747AlogP: 6.40#Rotatable Bonds: 17
Polar Surface Area: 225.89Molecular Species: NEUTRALHBA: 13HBD: 1
#RO5 Violations: 3HBA (Lipinski): 16HBD (Lipinski): 1#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.96CX Basic pKa: CX LogP: 5.79CX LogD: 5.68
Aromatic Rings: 5Heavy Atoms: 57QED Weighted: 0.05Np Likeness Score: 0.02

References

1. Wang J, Wang YJ, Chen ZS, Kwon CH..  (2014)  Synthesis and evaluation of sulfonylethyl-containing phosphotriesters of 3'-azido-3'-deoxythymidine as anticancer prodrugs.,  22  (21): [PMID:25440502] [10.1016/j.bmc.2014.09.046]

Source